My Blog
1st case in India on : 30th January, 2020
Today is Day : 541
New Cases Today : 35342
Recovered Cases Today : 38740
Deaths Today : 483
Total Cases till date : 31293063
Total Active Cases : 405513
Total Recovered Cases : 30468080
Total Deaths : 419470
Active Cases (%) : 1.30%
Recovered Cases (%) : 97.36%
Mortality (%) : 1.34%
Total Vaccinations done since 16th January, 2021 : 42,34,17,030
Source: Ministry Of Health & Family Welfare, Government Of India
1st case in India on : 30th January, 2020
Today is Day : 540
New Cases Today : 41383
Recovered Cases Today : 38652
Deaths Today : 507
Total Cases till date : 31257721
Total Active Cases : 409394
Total Recovered Cases : 30429340
Total Deaths : 418987
Active Cases (%) : 1.31%
Recovered Cases (%) : 97.35%
Mortality (%) : 1.34%
Total Vaccinations done since 16th January, 2021 : 41,78,51,151
Source: Ministry Of Health & Family Welfare, Government Of India
1st case in India on : 30th January, 2020
Today is Day : 539
New Cases Today : 42015
Recovered Cases Today : 36977
Deaths Today : 3998
Total Cases till date : 31216338
Total Active Cases : 407170
Total Recovered Cases : 30390688
Total Deaths : 418480
Active Cases (%) : 1.30%
Recovered Cases (%) : 97.36%
Mortality (%) : 1.34%
Total Vaccinations done since 16th January, 2021 : 41,54,72,455
Source: Ministry Of Health & Family Welfare, Government Of India
1st case in India on : 30th January, 2020
Today is Day : 538
New Cases Today : 30093
Recovered Cases Today : 45254
Deaths Today : 374
Total Cases till date : 31174323
Total Active Cases : 406130
Total Recovered Cases : 30353711
Total Deaths : 414482
Active Cases (%) : 1.30%
Recovered Cases (%) : 97.37%
Mortality (%) : 1.33%
Total Vaccinations done since 16th January, 2021 : 41,18,46,401
Source: Ministry Of Health & Family Welfare, Government Of India
Early treatment with low-molecular-weight heparin (LMWH) reduces the risk for death in patients with COVID-19, a retrospective cohort study shows.
Heparin could reduce the risk for blood clots, said Andrea De Vito, MD, from the Unit of Infectious Diseases at the University of Sassari, Sassari, Italy, during his online presentation of the findings at the 31st European Congress of Clinical Microbiology & Infectious Diseases.
“Several studies try to describe the role played by coagulopathies in COVID-19 death,” but the mechanism causing them is still unclear, De Vito explained.
Some guidelines have suggested heparin as a treatment for hospitalized COVID patients, but few have looked at nonhospitalized patients. In fact, the National Institutes of Health discourages the use of heparin in nonhospitalized COVID patients, and guidance for the home care of COVID patients from the World Health Organization doesn’t mention heparin treatment at all, he said.